deguelin has been researched along with Cancer of Esophagus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Liang, Q; Liu, H; Liu, W; Yu, X; Zhou, L | 1 |
| Baba, Y; Kato, Y | 1 |
| Bai, ML; Li, HJ; Zhang, LX | 1 |
3 other study(ies) available for deguelin and Cancer of Esophagus
| Article | Year |
|---|---|
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma.
Topics: Animals; Apoptosis; Aurora Kinase B; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Mice; Rotenone; Xenograft Model Antitumor Assays | 2017 |
Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cetuximab; Drug Therapy, Combination; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; G1 Phase Cell Cycle Checkpoints; Humans; Rotenone; Survival Rate | 2017 |
[Effects of deguelin on the proliferation and apoptosis of human esophageal cancer cell Ec-109: an experimental research].
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplasms; Humans; Proto-Oncogene Proteins c-bcl-2; Rotenone | 2013 |